최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biomolecules & therapeutics, v.28 no.4, 2020년, pp.302 - 310
Nepal, Mahesh Raj (College of Pharmacy, Yeungnam University) , Jeong, Tae Cheon (College of Pharmacy, Yeungnam University)
Botulinum toxins are neurotoxic modular proteins composed of a heavy chain and a light chain connected by a disulfide bond and are produced by Clostridium botulinum. Although lethally toxic, botulinum toxin in low doses is clinically effective in numerous medical conditions, including muscle spastic...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Alshadwi A. Nadershah M. Osborn T. 2015 Therapeutic applications of botulinum neurotoxins in head and neck disorders Saudi Dent. J. 27 3 11 10.1016/j.sdentj.2014.10.001 25544809
Benedetto A. V. 1999 The cosmetic uses of botulinum toxin type A Int. J. Dermatol. 38 641 655 10.1046/j.1365-4362.1999.00722.x 10517680
Bigalke H. Rummel A. 2015 Botulinum neurotoxins: qualitative and quantitative analysis using the mouse phrenic nerve hemidiaphragm assay (MPN) Toxins 7 4895 4905 10.3390/toxins7124855 26610569
Bjornstad K. Aberg A. T. Kalb S. R. Wang D. Barr J. R. Bondesson U. Hedeland M. 2014 Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum Anal. Bioanal. Chem. 406 7149 7161 10.1007/s00216-014-8170-4 25228079
Boyer A. E. Moura H. Woolfitt A. R. Kalb S. R. McWilliams L. G. Pavlopoulos A. Schmidt J. G. Ashley D. L. Barr J. R. 2005 From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry Anal. Chem. 77 3916 3924 10.1021/ac050485f 15987092
Bulbring E. 1946 Observations on the isolated phrenic nerve diaphragm preparation of the rat Br. J. Pharmacol. Chemother. 1 38 61 10.1111/j.1476-5381.1946.tb00025.x 20999334
Bushara K. O. Park D. M. Jones J. C. Schutta H. S. 1996 Botulinum toxin-a possible new treatment for axillary hyperhidrosis Clin. Exp. Dermatol. 21 276 278 10.1111/j.1365-2230.1996.tb00093.x 8959898
Cai S. Singh B. R. Sharma S. 2007 Botulism diagnostics: from clinical symptoms to in vitro assays Crit. Rev. Microbiol. 33 109 125 10.1080/10408410701364562 17558660
apek P. Dickerson T. 2010 Sensing the deadliest toxin: technologies for botulinum neurotoxin detection Toxins 2 24 53 10.3390/toxixlink010024 22069545
Carruthers J. D. Carruthers A. 2002 Cosmetic use of botulinum toxin for treatment of downturned mouth United States patent US6358917B1
Cheng L. W. Land K. M. Stanker L. H. Morse S. A. 2012 Current methods for detecting the presence of botulinum neurotoxins in food and other biological samples Bioterrorism IntechOpen London 1 18
Cheng L. W. Stanker L. H. 2013 Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum J. Agric. Food Chem. 61 755 760 10.1021/jf3041963 23265581
Cox L. Cameron A. P. 2014 OnabotulinumtoxinA for the treatment of overactive bladder Res. Rep. Urol. 6 79 89 10.2147/RRU.S43125 25157339
Dressler D. Dirnberger G. Bhatia K. P. Irmer A. Quinn N. P. Bigalke H. Marsden C. D. 2000 Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay Mov. Disord. 15 973 976 10.1002/1531-8257(200009)15:5<973::AID-MDS1031>3.0.CO;2-X 11009207
Dressler D. Saberi F. A. Barbosa E. R. 2005 Botulinum toxin: mechanisms of action Arq. Neuropsiquiatr. 63 180 185 10.1590/S0004-282X2005000100035 15830090
Dunning F. M. Piazza T. M. Zeytin F. N. Tucker W. C. 2014 Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays J. Vis. Exp. 3 e51170 10.3791/51170 24638074
Duthie J. B. Vincent M. Herbison G. P. Wilson D. I. Wilson D. 2011 Botulinum toxin injections for adults with overactive bladder syndrome Cochrane Database Syst. Rev. 7 CD005493 10.1002/14651858.CD005493.pub3 22161392
Ekong T. A. Feavers I. M. Sesardic D. 1997 Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro Microbiology 143 3337 3347 10.1099/00221287-143-10-3337 9353935
Escher C. M. Paracka L. Dressler D. Kollewe K. 2017 Botulinum toxin in the management of chronic migraine: clinical evidence and experience Ther. Adv. Neurol. Disord. 10 127 135 10.1177/1756285616677005 28382110
Fach P. Micheau P. Mazuet C. Perelle S. Popoff M. 2009 Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum , Clostridium baratii and Clostridium butyricum J. Appl. Microbiol. 107 465 473 10.1111/j.1365-2672.2009.04215.x 19291235
Food and Drug Administration 2017 Laboratory methods: bacteriological analytical manual (BAM) Available from: https://www.fda.gov/food/laboratory-methods-food/bam-clostridium-botulinum/
Fernandez-Salas E. Wang J. Molina Y. Nelson J. B. Jacky B. P. Aoki K. R. 2012 Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay PLoS ONE 7 e49516 10.1371/journal.pone.0049516 23185348
Ferreira J. L. 2001 Comparison of amplified ELISA and mouse bioassay procedures for determination of botulinal toxins A, B, E, and F J. AOAC Int. 84 85 88 10.1093/jaoac/84.1.85 11234855
Forster R. J. Bertoncello P. Keyes T. E. 2009 Electrogenerated chemiluminescence Annu. Rev. Anal. Chem. 2 359 385 10.1146/annurev-anchem-060908-155305 20636067
Heckmann M. Ceballos-Baumann A. O. Plewig G. 2001 Botulinum toxin A for axillary hyperhidrosis (excessive sweating) N. Engl. J. Med. 344 488 493 10.1056/NEJM200102153440704 11172190
Hodowanec A. Bleck T. P. Bennett J. E. Dolin R. Blaser M. J. 2015 Botulism ( Clostridium botulinum ) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 8th ed. Elsevier Philadelphia 2763 2767.e2
Kalb S. Baudys J. Wang D. Barr J. 2015 Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples Toxins 7 1765 1778 10.3390/toxins7051765 25996606
Keller J. E. Neale E. A. 2001 The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A J. Biol. Chem. 276 13476 13482 10.1074/jbc.M010992200 11278807
Kerner J. 1817 Vergiftung durch verdorbene Wurste Tubinger Blatt Naturwissenschaften Arzneykunde 3 1 25
Kiris E. Nuss J. E. Burnett J. C. Kota K. P. Koh D. C. Wanner L. M. Torres-Melendez E. Gussio R. Tessarollo L. Bavari S. 2011 Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery Stem Cell Res. 6 195 205 10.1016/j.scr.2011.01.002 21353660
Lentz J. Weingrow D. 2018 Bulbar muscle weakness in the setting of therapeutic botulinum injections Clin. Pract. Cases Emerg. Med. 2 330 333 10.5811/cpcem.2018.8.39178 30443619
Lindstrom M. Korkeala H. 2006 Laboratory diagnostics of botulism Clin. Microbiol. Rev. 19 298 314 10.1128/CMR.19.2.298-314.2006 16614251
Lindstrom M. Keto R. Markkula A. Nevas M. Hielm S. Korkeala H. 2001 Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material Appl. Environ. Microbiol. 67 5694 5699 10.1128/AEM.67.12.5694-5699.2001 11722924
de Medici D. Anniballi F. Wyatt G. M. Lindstrom M. Messelhausser U. Aldus C. F. Delibato E. Korkeala H. Peck M. W. Fenicia L. 2009 Multiplex PCR for detection of botulinum neurotoxin-producing clostridia in clinical, food, and environmental samples Appl. Environ. Microbiol. 75 6457 6461 10.1128/AEM.00805-09 19684163
Nawrocki E. M. Bradshaw M. Johnson E. A. 2018 Botulinum neurotoxin-encoding plasmids can be conjugatively transferred to diverse clostridial strains Sci. Rep. 8 3100 10.1038/s41598-018-21342-9 29449580
Nigam P. K. Nigam A. 2010 Botulinum toxin Indian J. Dermatol. 55 8 14 10.4103/0019-5154.60343 20418969
Nuss J. E. Ruthel G. Tressler L. E. Wanner L. M. Torres-Melendez E. Hale M. L. Bavari S. 2010 Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies J. Biomol. Screen. 15 42 51 10.1177/1087057109354779 19965805
Parks B. A. Shearer J. D. Baudys J. Kalb S. R. Sanford D. C. Pirkle J. L. Barr J. R. 2011 Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry Anal. Chem. 83 9047 9053 10.1021/ac201910q 22017298
Peck M. 2006 Clostridiumbotulinum and the safety of minimally heated, chilled foods: an emerging issue? J. Appl. Microbiol. 101 556 570 10.1111/j.1365-2672.2006.02987.x 16907806
Pellett S. 2013 Progress in cell based assays for botulinum neurotoxin detection Curr. Top. Microbiol. Immunol. 364 257 285 10.1007/978-3-662-45790-0_12 23239357
Pirazzini M. Rossetto O. Eleopra R. Montecucco C. 2017 Botulinum neurotoxins: biology, pharmacology, and toxicology Pharmacol. Rev. 69 200 235 10.1124/pr.116.012658 28356439
Rasetti-Escargueil C. Liu Y. Rigsby P. Jones R. G. A. Sesardic D. 2011 Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies Toxicon 57 1008 1016 10.1016/j.toxicon.2011.04.003 21513727
Rasooly R. Do P. M. 2008 Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A Appl. Environ. Microbiol. 74 4309 4313 10.1128/AEM.00617-08 18515481
Rheaume C. Cai B. Wang J. Fernandez-Salas E. Aoki K. Francis J. Broide R. 2015 A highly specific monoclonal antibody for botulinum neurotoxin type A-cleaved SNAP25 Toxins 7 2354 2370 10.3390/toxins7072354 26114335
Rosen O. Feldberg L. Yamin T. S. Dor E. Barnea A. Weissberg A. Zichel R. 2017 Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E Sci. Rep. 7 14859 10.1038/s41598-017-14911-x 29093524
Rosen O. Feldberg L. Gura S. Zichel R. 2015 A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay Anal. Biochem. 473 7 10 10.1016/j.ab.2014.09.016 25277815
Rust A. Doran C. Hart R. Binz T. Stickings P. Sesardic D. Peden A. A. Davletov B. 2017 A cell line for detection of botulinum neurotoxin type B Front. Pharmacol. 8 796 10.3389/fphar.2017.00796 29170639
Sesardic D. Das R. G. 2007 Alternatives to the LD 50 assay for botulinum toxin potency testing: strategies and progress towards refinement, reduction and replacement Proceeding of 6th World Congress on Alternatives and Animal Use in the Life Sciences Tokyo, Japan 21 25
Sesardic D. McLellan K. Ekong T. A. Das R. G. 1996 Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin Pharmacol. Toxicol. 78 283 288 10.1111/j.1600-0773.1996.tb01376.x 8737961
Sharma S. K. Ferreira J. L. Eblen B. S. Whiting R. C. 2006 Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies Appl. Environ.Microbiol. 72 1231 1238 10.1128/AEM.72.2.1231-1238.2006 16461671
Silberstein S. Mathew N. Saper J. Jenkins S. 2000 Botulinum toxin type A as a migraine preventive treatment Headache 40 445 450 10.1046/j.1526-4610.2000.00066.x 10849039
Simon S. Fiebig U. Liu Y. Tierney R. Dano J. Worbs S. Endermann T. Nevers M. C. Volland H. Sesardic D. 2015 Recommended immunological strategies to screen for botulinum neurotoxin-containing samples Toxins 7 5011 5034 10.3390/toxins7124860 26703727
Small R. 2014 Botulinum toxin injection for facial wrinkles Am. Fam. Physician 90 168 175 25077722
Smith T. J. Hill K. K. Raphael B. H. 2015 Historical and current perspectives on Clostridium botulinum diversity Front. Microbiol. 166 290 302 10.1016/j.resmic.2014.09.007 25312020
Snow B. J. Tsui J. K. Bhatt M. H. Varelas M. Hashimoto S. A. Calne D. B. 1990 Treatment of spasticity with botulinum toxin: a double-blind study Ann. Neurol. 28 512 515 10.1002/ana.410280407 2252363
Stephens M. L. 2005 Nomination of alternative methods to replace the mouse LD50 assay for botulinum toxin potency testing Test method nomination to the ICCVAM New York, USA
Szabo E. A. Pemberton J. M. Desmarchelier P. M. 1993 Detection of the genes encoding botulinum neurotoxin types A to E by the polymerase chain reaction Appl. Environ. Microbiol. 59 3011 3020 10.1128/AEM.59.9.3011-3020.1993 8215372
Taylor K. Gericke C. Alvarez L. R. 2019 Botulinum toxin testing on animals is still a Europe-wide issue ALTEX 36 81 90 10.14573/altex.1807101 30303513
Thirunavukkarasu N. Johnson E. Pillai S. Hodge D. Stanker L. Wentz T. Singh B. Venkateswaran K. McNutt P. Adler M. Brown E. Hammack T. Burr D. Sharma S. 2018 Botulinum neurotoxin detection methods for public health response and surveillance Front. Bioeng. Biotechnol. 6 80 10.3389/fbioe.2018.00080 29988463
Tornqvist E. Annas A. Granath B. Jalkesten E. Cotgreave I. Oberg M. 2014 Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing PLoS ONE 9 e101638 10.1371/journal.pone.0101638 25054864
Valenti G. Fiorani A. Li H. Sojic N. Paolucci F. 2016 Essential role of electrode materials in electrochemiluminescence applications ChemElectroChem 3 1990 1997 10.1002/celc.201600602
von Berg L. Stern D. Pauly D. Mahrhold S. Weisemann J. Jentsch L. Hansbauer E. M. Muller C. Avondet M. A. Rummel A. Dorner M. B. Dorner B. G. 2019 Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology Sci. Rep. 9 5531 10.1038/s41598-019-41722-z 30940836
Wictome M. Newton K. Jameson K. Hallis B. Dunnigan P. Mackay E. Clarke S. Taylor R. Gaze J. Foster K. 1999 Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay Appl. Environ. Microbiol. 65 3787 3792 10.1128/AEM.65.9.3787-3792.1999 10473376
Wilder-Kofie T. D. Luquez C. Adler M. Dykes J. K. Coleman J. D. Maslanka S. E. 2011 An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection Comp. Med. 61 235 242 21819693
Yadirgi G. Stickings P. Rajagopal S. Liu Y. Sesardic D. 2017 Immuno-detection of cleaved SNAP-25 from differentiated mouse embryonic stem cells provides a sensitive assay for determination of botulinum A toxin and antitoxin potency J. Immunol. Methods 451 90 99 10.1016/j.jim.2017.09.007 28943257
Zhang Y. Lou J. Jenko K. L. Marks J. D. Varnum S. M. 2012 Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays Anal. Biochem. 430 185 192 10.1016/j.ab.2012.08.021 22935296
Zechmeister T. C. Farnleitner A. H. Rocke T. E. Pittner F. Rosengarten R. Mach R. L. Herzig A. Kirschner A. K. 2002 PCR and ELISA: in vitro alternatives to the mouse-bioassay for assessing the botulinum-neurotoxin-C1 production potential in environmental samples? ALTEX 19 Suppl 1 49 54
※ AI-Helper는 부적절한 답변을 할 수 있습니다.